| Cite this article: |
| JIA Yuhan,GAO Tianshu,PEI Naiqi,ZHENG Qiaohong,LI Jiaqi,LIU Yijiao,QIAN Youqiao,MA Yang,CHEN Hui,YE Yuanyuan,ZHAO Jiaxin,ZHOU Yi,CHEN Xiaoqing,WANG Xing,CHEN Zhen.Research process in pathogenesis of gouty arthritis[J].Journal Of Pharmaceutical Research,2024,43(7):684-688[Click to copy] |
|
| |
|
|
| This article has been viewed: 3265times Download 3672次 |
 Scan with your phone! |
| 痛风性关节炎发病机制的研究进展 |
| 贾昱晗1,高天舒1,裴乃琪2,郑巧红2,李嘉琦1,刘一娇1,钱有桥3,马扬1,陈慧4,叶圆媛1,赵嘉鑫1,周怡1,陈晓晴1,王星1,陈真1 |
|
|
| (1.中国药科大学药学院,江苏 南京 211198;2.中国药科大学基础医学与临床药学学院,江苏 南京 211198;3.中国药科大学孟目的学院,江苏 南京 211198;4.中国药科大学生命科学与技术学院,江苏 南京 211198) |
|
| 摘要: |
| 痛风性关节炎是由体内尿酸盐沉积导致的以关节疼痛坏死为主要病症的疾病,通常简称为痛风。痛风的发病机制复杂,已上市的治疗药物少。由于患病人数的上升,痛风得到了研究人员的广泛关注。近些年中药治疗痛风展现出了良好的效果与优势,但就治疗靶点与治疗机制的研究并不完善。为进一步开发治疗痛风的药物,特对痛风的发病机制进行综述,以期为后续研究做出指导。 |
| 关键词: 痛风性关节炎 高尿酸血症 炎症 转录因子 |
| DOI:10.13506/j.cnki.jpr.2024.07.011 |
| 基金项目:国家级大学生创新创业训练计划项目成果(No.202310316005Z);江苏省基础研究计划(自然科学基金)——青年(No.BK20180574);大学生创新创业训练计划项目成果(No.2023103161005) |
|
Publication Date:July 25, 2024
|
|
| Research process in pathogenesis of gouty arthritis |
| JIA Yuhan1,GAO Tianshu1,PEI Naiqi2,ZHENG Qiaohong2,LI Jiaqi1,LIU Yijiao1,QIAN Youqiao3,MA Yang1,CHEN Hui4,YE Yuanyuan1,ZHAO Jiaxin1,ZHOU Yi1,CHEN Xiaoqing1,WANG Xing1,CHEN Zhen1 |
| (1.School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China; 2.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China;3.College of Mudi Meng honors,China Pharmaceutical University, Nanjing 211198, China; 4. College of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China) |
| Abstract: |
| Gouty arthritis is a disease caused by the deposition of uric acid in body, and it is usually known as gout. Joint pain and necrosis always occars to the patients. The pathogenesis of gout is complex. Only few therapeutic drugs for gout are on the market. Due to the increase in the number of patients, gout has been widely concerned by researchers. In recent years, traditional Chinese medicine has shown good effects and advantages in the treatment of gout, but the research on the treatment target and treatment mechanism is not clear. In order to further develop drugs to treat gout, the pathogenesis of gout is reviewed in order to provide guidance for follow-up research. |
| Key words: Gouty arthritis Hyperuricemia Inflammation Transcription factor |
|
|
|
|
|